Published in J Virol on November 01, 1993
Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots. J Virol (2002) 2.50
Marked infidelity of human immunodeficiency virus type 1 reverse transcriptase at RNA and DNA template ends. Proc Natl Acad Sci U S A (1994) 2.12
The remarkable frequency of human immunodeficiency virus type 1 genetic recombination. Microbiol Mol Biol Rev (2009) 2.02
Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications. J Virol (1995) 1.62
Homologous recombination occurs in a distinct retroviral subpopulation and exhibits high negative interference. J Virol (1997) 1.57
Replication infidelity during a single cycle of Ty1 retrotransposition. Proc Natl Acad Sci U S A (1996) 1.45
Structural determinants of murine leukemia virus reverse transcriptase that affect the frequency of template switching. J Virol (2000) 1.38
Effect of distance between homologous sequences and 3' homology on the frequency of retroviral reverse transcriptase template switching. J Virol (1999) 1.23
Sequence variability within the tobacco retrotransposon Tnt1 population. EMBO J (1995) 1.20
Mutation rates and intrinsic fidelity of retroviral reverse transcriptases. Viruses (2009) 1.19
Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary. J Virol (2001) 1.14
High rate of genetic recombination in murine leukemia virus: implications for influencing proviral ploidy. J Virol (2006) 1.08
Y586F mutation in murine leukemia virus reverse transcriptase decreases fidelity of DNA synthesis in regions associated with adenine-thymine tracts. Proc Natl Acad Sci U S A (2002) 1.01
Transfer of single gene-containing long terminal repeats into the genome of mammalian cells by a retroviral vector carrying the cre gene and the loxP site. J Virol (1996) 0.89
Human immunodeficiency virus type 1 transductive recombination can occur frequently and in proportion to polyadenylation signal readthrough. J Virol (2004) 0.86
Transduction of cellular sequence by a human immunodeficiency virus type 1-derived vector. J Virol (2001) 0.86
Frequency of missense mutations in the coding region of a eukaryotic gene transferred by retroviral vectors. J Virol (2002) 0.80
An array of novel murine spleen focus-forming viruses that activate the erythropoietin receptor. J Virol (1998) 0.77
An internal deletion enhances the transcriptional activity of a recombinant retrovirus in hematopoietic cells in vivo. J Virol (1994) 0.77
Retroviral vectors for analysis of viral mutagenesis and recombination. Viruses (2014) 0.76
Isolation of new oncogenic forms of the murine c-fms gene. J Virol (1995) 0.75
Quantitative analysis of clinically relevant mutations occurring in lymphoid cells harboring gamma-retrovirus-encoded hsvtk suicide genes. Gene Ther (2008) 0.75
A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res (1984) 181.98
Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science (1985) 95.08
Human gene therapy comes of age. Nature (1992) 13.26
Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. Cell (1986) 9.01
New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol Cell Biol (1984) 8.63
A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol (1988) 7.87
Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors. Nature (1985) 7.54
Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc Natl Acad Sci U S A (1990) 6.66
Retroviral recombination and reverse transcription. Science (1990) 6.27
Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol (1991) 6.19
High frequency of aberrant expression of Moloney murine leukemia virus in clonal infections. Cell (1978) 5.72
Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations. Proc Natl Acad Sci U S A (1990) 4.72
Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell (1984) 4.29
Mechanism of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase. Science (1992) 3.81
Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus. Cell (1981) 3.80
Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. Proc Natl Acad Sci U S A (1990) 3.76
Genetic recombination of human immunodeficiency virus. J Virol (1989) 3.61
Nucleotide sequence of mouse satellite DNA. Nucleic Acids Res (1981) 3.04
Determination of the rate of base-pair substitution and insertion mutations in retrovirus replication. J Virol (1988) 2.88
Construction and analysis of deletion mutations in the U5 region of Moloney murine leukemia virus: effects on RNA packaging and reverse transcription. J Virol (1989) 2.69
Generation of diversity in retroviruses. Annu Rev Genet (1990) 2.53
Mechanism of transduction by retroviruses. Science (1992) 2.37
Characterization of large deletions occurring during a single round of retrovirus vector replication: novel deletion mechanism involving errors in strand transfer. J Virol (1991) 2.34
Homologous recombination of copackaged retrovirus RNAs during reverse transcription. J Virol (1992) 2.29
Template-directed pausing of DNA synthesis by HIV-1 reverse transcriptase during polymerization of HIV-1 sequences in vitro. J Biol Chem (1993) 2.26
The mechanism of interference between an avian leukosis virus and Rous sarcoma virus. I. Establishment of interference. Virology (1966) 2.22
High-frequency deletion between homologous sequences during retrotransposition of Ty elements in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1987) 2.12
Involvement of directly repeated sequences in the generation of deletions of the avian sarcoma virus src gene. J Virol (1983) 1.94
Determination of the mutation rate of a retrovirus. J Virol (1988) 1.75
Comparison of Moloney murine leukemia virus mutation rate with the fidelity of its reverse transcriptase in vitro. J Biol Chem (1992) 1.73
Spontaneous variation and synthesis in the U3 region of the long terminal repeat of an avian retrovirus. J Virol (1982) 1.69
Truncated gag-related proteins are produced by large deletion mutants of Rous sarcoma virus and form virus particles. J Virol (1985) 1.63
Curvature of mouse satellite DNA and condensation of heterochromatin. Cell (1987) 1.41
Evolutionary variants of Rous sarcoma virus: large deletion mutants do not result from homologous recombination. J Virol (1985) 1.39
3' junctions of oncogene-virus sequences and the mechanisms for formation of highly oncogenic retroviruses. J Virol (1993) 1.36
Direct determination of the point mutation rate of a murine retrovirus. J Virol (1992) 1.25
Mouse satellite DNA is transcribed in senescent cardiac muscle. J Biol Chem (1990) 1.14
Characterization of a highly repetitive sequence DNA family in rat. J Mol Biol (1981) 1.12
RNA replication by nuclear satellite DNA in different mouse cells. Biochem Biophys Res Commun (1968) 0.93
Transcription of satellite DNA in mouse L-cells. Can J Biochem (1973) 0.82
High mutation rate of a spleen necrosis virus-based retrovirus vector. Mol Cell Biol (1986) 3.57
High rate of recombination throughout the human immunodeficiency virus type 1 genome. J Virol (2000) 3.09
The thermal stability of oligonucleotide duplexes is sequence independent in tetraalkylammonium salt solutions: application to identifying recombinant DNA clones. Nucleic Acids Res (1988) 2.95
T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. J Immunol (1987) 2.93
T cell selection in the thymus. Immunol Rev (1988) 2.53
Stimulation of in vitro transcription from heterologous promoters by the simian virus 40 enhancer. Proc Natl Acad Sci U S A (1984) 2.44
Mature murine B and T cells transferred to SCID mice can survive indefinitely and many maintain a virgin phenotype. J Exp Med (1991) 2.25
A promoterless retroviral vector indicates that there are sequences in U3 required for 3' RNA processing. Proc Natl Acad Sci U S A (1987) 2.13
Compartmentalization of MHC class II gene expression in transgenic mice. Cell (1988) 2.08
Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial. Gastroenterology (1996) 1.85
Mechanisms of retroviral mutation. Trends Microbiol (1996) 1.85
Comparison of Moloney murine leukemia virus mutation rate with the fidelity of its reverse transcriptase in vitro. J Biol Chem (1992) 1.73
A gene therapy approach for treating T-cell-mediated autoimmune diseases. Blood (2001) 1.69
Analgesic effect of topical sodium diclofenac 0.1% drops during retinal laser photocoagulation. Br J Ophthalmol (2000) 1.64
Appendectomy is more frequent but not a risk factor in Crohn's disease while being protective in ulcerative colitis: a comparison of surgical procedures in inflammatory bowel disease. Am J Gastroenterol (2001) 1.63
Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications. J Virol (1995) 1.62
Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors. EMBO J (1999) 1.61
The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD. Aliment Pharmacol Ther (2012) 1.57
Immobilization of DNA via oligonucleotides containing an aldehyde or carboxylic acid group at the 5' terminus. Nucleic Acids Res (1987) 1.55
The nature of human immunodeficiency virus type 1 strand transfers. J Biol Chem (1998) 1.52
Inducible human immunodeficiency virus type 1 packaging cell lines. J Virol (1996) 1.49
Defective induction of antigen-reactive proliferating T cells in B cell-deprived mice. Eur J Immunol (1981) 1.49
Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice. J Immunol (1983) 1.42
Isolation of a cDNA clone encoding a high molecular weight precursor to a 6-kDa pulmonary surfactant-associated protein. J Biol Chem (1987) 1.40
Transgenic HLA-DR alpha faithfully reconstitutes IE-controlled immune functions and induces cross-tolerance to E alpha in E alpha 0 mutant mice. Cell (1989) 1.37
Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations. Int Immunol (2001) 1.36
Interferon, double-stranded RNA, and RNA degradation. Isolation of homogeneous pppA(2'p5'A)n-1 synthetase from Ehrlich ascites tumor cells. J Biol Chem (1980) 1.30
In vivo analysis of a new lacZ retrovirus vector suitable for cell lineage marking in avian and other species. Exp Cell Res (1991) 1.24
Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis. J Neuroimmunol (1995) 1.23
Mutations of conserved cysteine residues in the CWLC motif of the oncoretrovirus SU protein affect maturation and translocation. Virology (1995) 1.17
Restricted tissue distribution of Mlsa determinants. Stimulation of Mlsa-reactive T cells by B cells but not by dendritic cells or macrophages. J Exp Med (1989) 1.16
Juxtaposition of an active promoter to vsp genes via site-specific DNA inversions generates antigenic variation in Mycoplasma bovis. J Bacteriol (2001) 1.15
Rapid hybridization kinetics of DNA attached to submicron latex particles. Nucleic Acids Res (1987) 1.13
Intrachromosomal recombination within the vsp locus of Mycoplasma bovis generates a chimeric variable surface lipoprotein antigen. Infect Immun (2001) 1.11
Survival of diffuse large cell lymphoma. A multivariate analysis including dose intensity variables. Cancer (1990) 1.08
Spleen necrosis virus, an avian retrovirus, can infect primate cells. J Virol (1991) 1.05
Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis. J Neuroimmunol (1992) 1.04
Spontaneous remission of autoimmune encephalomyelitis is inhibited by splenectomy, thymectomy or ageing. Nature (1980) 1.01
A nickel chelate microtiter plate assay for six histidine-containing proteins. Anal Biochem (1996) 1.00
Metastatic properties conferred on nonmetastatic tumors by hybridization of spleen B-lymphocytes with plasmacytoma cells. J Natl Cancer Inst (1981) 0.99
H-2 gene products influence susceptibility of target thyroid gland to damage in experimental autoimmune thyroiditis. Eur J Immunol (1980) 0.99
Reticuloendotheliosis type C and primate type D oncoretroviruses are members of the same receptor interference group. J Virol (1992) 0.99
Prolonged survival in vivo of unprimed B cells responsive to a T-independent antigen. J Exp Med (1985) 0.96
Effects of current cigarette smoking on clinical course of Crohn's disease and ulcerative colitis. Dig Dis Sci (2001) 0.96
Synthesis of (2'-5')(A)n from ATP. Characteristics of the reaction catalyzed by (2'-5')(A)n synthetase purified from mouse Ehrlich ascites tumor cells treated with interferon. J Biol Chem (1980) 0.96
T cell specificity in twice-irradiated F1----parent bone marrow chimeras: failure to detect a role for immigrant marrow-derived cells in imprinting intrathymic H-2 restriction. J Immunol (1986) 0.95
Lack of association between smoking and Crohn's disease but the usual association with ulcerative colitis in Jewish patients in Israel: a multicenter study. Am J Gastroenterol (2000) 0.95
Induction of MHC-restricted specificity and tolerance in the thymus. Immunol Res (1986) 0.95
An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins. Virology (2001) 0.95
In vivo antigen presentation by both brain parenchymal cells and hematopoietically derived cells during the induction of experimental autoimmune encephalomyelitis. J Immunol (1993) 0.93
Inhibition of Ly-6A antigen expression prevents T cell activation. J Exp Med (1990) 0.92
Discontinuous plus-strand DNA synthesis in human immunodeficiency virus type 1-infected cells and in a partially reconstituted cell-free system. J Virol (1997) 0.92
Dose-intensity analysis for CHOP chemotherapy in diffuse aggressive large cell lymphoma. Isr J Med Sci (1989) 0.92
Accessory cells and T cell activation. The relationship between two components of macrophage accessory cell function: I-A and IL1. Immunobiology (1984) 0.91
Defective induction of antigen-reactive proliferating T cells in B cell-deprived mice. II. Anti-mu treatment affects the initiation and recruitment of T cells. Eur J Immunol (1983) 0.90
A spleen necrosis virus-based retroviral vector which expresses two genes from a dicistronic mRNA. Virology (1992) 0.90
The effect of febrile temperatures on biologic actions of interferons: abrogation of suppression of delayed-type hypersensitivity and antibody production. J Immunol (1984) 0.87
Pseudotyped REV/SRV retroviruses reveal restrictions to infection and host range within members of the same receptor interference group. Virology (1994) 0.87
Transduction of cellular sequence by a human immunodeficiency virus type 1-derived vector. J Virol (2001) 0.86
Physiology of B cells in mice with X-linked immunodeficiency. I. Size, migratory properties, and turnover of the B cell pool. J Immunol (1985) 0.85
Splenic B cells function as immunogenic antigen-presenting cells for the induction of effector T cells. Eur J Immunol (1983) 0.84
The mouse immunoglobulin heavy-chain gene enhancer contains sequences that inhibit transcription in vitro in HeLa cell extracts. Mol Cell Biol (1986) 0.84
Assessment of high-sensitivity CRP as a marker of micro-inflammation in irritable bowel syndrome. Neurogastroenterol Motil (2011) 0.84
N2- and C8-substituted oligodeoxynucleotides with enhanced thrombin inhibitory activity in vitro and in vivo. J Med Chem (1998) 0.83
Regulated lentiviral packaging cell line devoid of most viral cis-acting sequences. Virology (1998) 0.83
A murine model for B-lymphocyte somatic cell gene therapy. Proc Natl Acad Sci U S A (1994) 0.83
Assessment of the esophageal wall by endoscopic ultrasonography in patients with nutcracker esophagus. Gastrointest Endosc (1997) 0.83
Use of single-cycle analysis to study rates and mechanisms of retroviral mutation. Methods (1997) 0.82
Refractive and structural changes in infantile periocular capillary haemangioma treated with propranolol. Eye (Lond) (2011) 0.82
Studies with pure mouse Ehrlich ascites tumor interferons alpha and beta: patterns of induction of (2'-5') (A)n synthetase and of a double-stranded RNA-dependent protein kinase in mouse cells and human cells. J Interferon Res (1981) 0.82
Involvement of the spleen in murine B cell differentiation. Eur J Immunol (1981) 0.81
Protective immunity to progressive tumors can be induced by antigen presented on regressor tumors. J Immunol (1987) 0.81
Group B streptococcal tricuspid valve endocarditis: a case report and review of literature. Int J Cardiol (1998) 0.81
Determination of retroviral mutation rates using spleen necrosis virus-based vectors and helper cells. Biotechnology (1991) 0.81
Antigen-induced proliferation assay for rabbit T lymphocytes. I. Characteristics of the response. Immunology (1980) 0.80
Injection of irradiated b16 melanoma genetically-modified to secrete IFN-alpha causes regression of an established tumor. Int J Oncol (1995) 0.80